Showing results (481-490 of 561) with videos related to

Sort By:
Pageof 57
Human Brain Mapping|June 8, 2000
Six-month test-retest reliability of MRI-defined PET measures of regional cerebral glucose metabolic rate in selected subcortical structuresS M Schaefer, H C Abercrombie, K A Lindgren, et al.
Biological Psychiatry|July 1, 1999
Thalamic metabolic rate predicts EEG alpha power in healthy control subjects but not in depressed patientsK A Lindgren, C L Larson, S M Schaefer, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 26, 2000
Inverse relationship between protein intake and plasma free amino acids in healthy men at physical exerciseA H Forslund, L Hambraeus, H van Beurden, et al.
Upsala Journal of Medical Sciences|November 30, 2000
Engraftment and growth of transplanted pancreatic isletsP O Carlsson, A Andersson, C Carlsson, et al.
European Journal of Neurology|May 2, 2013
Are 25 SNPs from the CARDIoGRAM study associated with ischaemic stroke?H Lövkvist, M Sjögren, P Höglund, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 2, 2005
Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonistE S Burstein, J Ma, S Wong, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 21, 2014
Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndromeJean Y Tang, Albert S Chiou, Julian M Mackay-Wiggan, et al.
Neuroreport|November 27, 1998
Metabolic rate in the right amygdala predicts negative affect in depressed patientsH C Abercrombie, S M Schaefer, C L Larson, et al.
The Lancet. Oncology|November 14, 2016
Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trialJean Y Tang, Mina S Ally, Anita M Chanana, et al.
Psychopharmacology|July 20, 2004
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapineD M Weiner, H Y Meltzer, I Veinbergs, et al.
Pageof 57